Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Lupin Target Price Cut By Systematix After Q4 Results — Should You Buy, Sell Or Hold?

    4 hours ago

    The near-term earnings growth may be a challenge for Lupin as they should see impact of competition in their largest portfolio product, gTolvaptan in FY27, adds the brokerage.
    Click here to Read More
    Previous Article
    Stock Market Crash News Today Live Updates: Nifty Falls Below 23,900, Sensex Slides 900 Points; Hyundai India, Tata Consumer Up Over 3% After Q4 Results
    Next Article
    SBI Shares Fall 10% In Three Sessions — Should You Buy, Sell Or Hold?

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment